Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy

计划入组 50 人 · 首次发布于 2015 年 6 月 3 日

Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy

计划入组 44 人 · 首次发布于 2019 年 8 月 7 日

Peripheral Neurostimulation for Nerve Block Placement

计划入组 150 人 · 首次发布于 2024 年 8 月 22 日

Succinylated gelatin

Rx

B. BRAUN MEDICAL INC.

United States

B. Braun Medical SA

Switzerland

B. Braun Melsungen AG

Germany

B. Braun Launches First FDA-Approved Room-Temperature-Stable Rocuronium Bromide Prefilled Syringe

B. Braun Completes Full Acquisition of True Digital Surgery to Advance Digital Microsurgery Technology

B. Braun Introduces Revolutionary Emergency Department Nerve Block Tray to Reduce Opioid Use